Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Cellerino

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
CNS Drugs|March 21, 2020
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS PopulationGiacomo Boffa, Nicolò Bruschi, Maria Cellerino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2022
Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series studyVincenzo Daniele Boccia, Caterina Lapucci, Maria Cellerino, et al.
Journal of Clinical Neurology (Seoul, Korea)|September 5, 2022
Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography StudyAlessandro Masala, Ilaria Di Mola, Maria Cellerino, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 5, 2021
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple SclerosisMaria Cellerino, Luca Priano, Nicolò Bruschi, et al.
European Radiology Experimental|June 7, 2022
The role of disconnection in explaining disability in multiple sclerosisCaterina Lapucci, Simona Schiavi, Alessio Signori, et al.
Human Vaccines & Immunotherapeutics|July 21, 2022
Vaccinations in patients with multiple sclerosis: a real-world, single-center experienceElvira Sbragia, Dario Olobardi, Giovanni Novi, et al.
Journal of Clinical Neurology (Seoul, Korea)|May 19, 2022
Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography StudyAlessandro Masala, Ilaria Di Mola, Maria Cellerino, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 4, 2024
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein diseaseCaterina Lapucci, Vincenzo Daniele Boccia, Thoma Dario Clementi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 13, 2026
Functional and effective connectivity disruptions of the dopaminergic reward circuit in multiple sclerosis patients with depressionGiada Lombardi, Elisa Leveraro, Emilio Cipriano, et al.
Multiple Sclerosis and Related Disorders|August 24, 2025
The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimodTommaso Sirito, Emilio Cipriano, Caterina Lapucci, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
CNS Drugs|March 21, 2020
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS PopulationGiacomo Boffa, Nicolò Bruschi, Maria Cellerino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2022
Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series studyVincenzo Daniele Boccia, Caterina Lapucci, Maria Cellerino, et al.
Journal of Clinical Neurology (Seoul, Korea)|September 5, 2022
Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography StudyAlessandro Masala, Ilaria Di Mola, Maria Cellerino, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|January 5, 2021
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple SclerosisMaria Cellerino, Luca Priano, Nicolò Bruschi, et al.
European Radiology Experimental|June 7, 2022
The role of disconnection in explaining disability in multiple sclerosisCaterina Lapucci, Simona Schiavi, Alessio Signori, et al.
Human Vaccines & Immunotherapeutics|July 21, 2022
Vaccinations in patients with multiple sclerosis: a real-world, single-center experienceElvira Sbragia, Dario Olobardi, Giovanni Novi, et al.
Journal of Clinical Neurology (Seoul, Korea)|May 19, 2022
Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography StudyAlessandro Masala, Ilaria Di Mola, Maria Cellerino, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 4, 2024
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein diseaseCaterina Lapucci, Vincenzo Daniele Boccia, Thoma Dario Clementi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 13, 2026
Functional and effective connectivity disruptions of the dopaminergic reward circuit in multiple sclerosis patients with depressionGiada Lombardi, Elisa Leveraro, Emilio Cipriano, et al.
Multiple Sclerosis and Related Disorders|August 24, 2025
The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimodTommaso Sirito, Emilio Cipriano, Caterina Lapucci, et al.
Pageof 7